HIGGINS JOHN L

Average Profitability
13.79%
Insider Buys Quantity
7
Insider Buys Sum
$181,545.00
Insider Sells Quantity
36
Insider Sells Sum
$36.72M

Insider Activity of HIGGINS JOHN L

According to the SEC Form 4 filings, HIGGINS JOHN L, being in a position of

  1. director at Bio-Techne Corporation,
    оver the last 12 months, has bought 0 shares, and sold 4000 shares for $335,377,
    over all time since 2016-09-08, has bought 0 shares, and sold 53500 shares for $9.83M.

The largest purchase of all time was on 2014-08-15 and amounted to 1000 shares of Ligand Pharmaceuticals Incorporated for $54,970.

The largest sale of all time was on 2018-08-16 and amounted to 21507 shares of Ligand Pharmaceuticals Incorporated for $5.19M.

Biography of HIGGINS JOHN L

No biography is available at this moment.

2024-05-14SaleBio-Techne Corporation
TECH
director
4,000
0.0025%
$83.84$335,377-10.74%
2023-05-23SaleOmniAb, Inc.
OABI
director
9,000
0.0085%
$4.05$36,450+19.95%
2023-05-19SaleOmniAb, Inc.
OABI
director
1,000
0.0011%
$4.05$4,050+34.2%
2023-05-18SaleOmniAb, Inc.
OABI
director
50,000
0.05%
$3.89$194,500+32.02%
2022-12-16SaleLigand Pharmaceuticals Incorporated
LGND
director
10,000
0.0585%
$61.87$618,657+9.29%
2022-11-17SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
10,000
0.0593%
$78.32$783,173-11.04%
2022-08-10SaleBio-Techne Corporation
TECH
100
0.0003%
$374.89$37,490-14.58%
2022-06-07SaleBio-Techne Corporation
TECH
1,000
0.0025%
$364.31$364,310-10.27%
2020-11-06SaleBio-Techne Corporation
TECH
director
5,000
0.0128%
$300.35$1.5M+37.99%
2020-02-12SaleBio-Techne Corporation
TECH
director
10,000
0.0261%
$205.23$2.05M+27.98%
2019-06-04SaleBio-Techne Corporation
TECH
director
10,000
0.0264%
$203.67$2.04M+2.03%
2018-08-30SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
3,500
0.0166%
$258.25$903,875-52.06%
2018-08-23SaleBio-Techne Corporation
TECH
director
20,000
0.0442%
$156.48$3.13M+3.5%
2018-08-17SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
12,993
0.0602%
$243.00$3.16M-49.81%
2018-08-16SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
21,507
0.1024%
$241.33$5.19M-48%
2018-05-15SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
12,405
0.0051%
$16.14$200,217-13.7%
2018-02-15SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
9,000
0.0424%
$157.03$1.41M+8.91%
2018-01-24SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
22,500
0.1069%
$165.00$3.71M+4.52%
2018-01-19SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
28,099
0.0624%
$73.40$2.06M+9.87%
2017-11-17SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
2,258
0.0107%
$140.34$316,888+22.01%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.